Rare diseases
Investigational molecules
Locations
Back to Hungary560 clinical trials in Debrecen, Hungary across 2 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Phase IIb Study of AZD8965 versus Placebo in Adults with Idiopathic Pulmonary Fibrosis
HungaryA double‑blind, placebo‑controlled trial of oral BI 1015550 in patients with systemic sclerosis
HungaryStudy of AZD0486 plus rituximab versus standard chemotherapy drug combination in previously untreated follicular lymphoma patients
HungaryEfficacy and safety of lunsekimig in adults with inadequately controlled eosinophilic COPD: a randomized, double‑blind, placebo‑controlled trial
HungaryEfficacy and Safety of Inhaled Glycopyrronium Bromide Added to Budesonide and Formoterol Fumarate in Children 4‑12 Years with Asthma (Placebo‑Controlled)
HungaryRinatabart Sesutecan plus bevacizumab vs standard care as maintenance for recurrent platinum‑sensitive ovarian cancer after second‑line chemotherapy
HungaryStudy of AZD0901 (sonesitatug vedotin) with capecitabine ± rilvegostomig in adults with advanced stomach or esophageal cancer (Claudin‑18.2‑positive, HER2‑negative)
HungaryA Phase 2/3 Study of intravitreal mk-8748 versus aflibercept in adults with neovascular age‑related macular degeneration
HungaryEvaluation of NXT007 versus Emicizumab Prophylaxis in Patients with Hemophilia A
HungaryEfficacy and safety of indacaterol acetate (combined with glycopyrronium bromide and mometasone furoate) versus salmeterol/fluticasone in adolescents with asthma
HungaryVMX-C001 in Patients Taking Factor Xa Inhibitors Who Need Urgent Surgery or an Invasive Procedure With High Bleeding Risk
HungaryNipocalimab in Adults with Moderate to Severe Systemic Lupus Erythematosus
HungaryThe busiest research cities in the country
What the registry says about research in the country
Comprehensive studies evaluating novel treatments for plaque psoriasis and chronic urticaria. Multiple trials are investigating innovative therapies for both moderate to severe cases, including genital manifestations.
Focus on long-term safety and efficacy of new therapeutic agents for chronic skin conditions.
Leading research into heart failure prevention and cardiovascular disease management. Trials examining innovative treatments and preventive approaches for high-risk patients.
Emphasis on reducing major cardiovascular events and improving patient outcomes.
Groundbreaking research addressing obesity and type 2 diabetes. Studies evaluating combination therapies and novel approaches for weight management in diverse patient populations.
Investigation of treatments combining weight reduction with diabetes management.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
